LifeSplice Pharma is an early-stage biotech company that develops extraordinarily specific, potent, and long-lasting RNA-based drugs called 'Splice Modulating Oligomers' (SMOs) to treat severe neurological and non-neurological diseases with critical unmet medical needs.